Cardiovascular and Renal Outcomes of Mineralocorticoid Receptor Antagonist Use in PARAGON-HF
Karola Jering, Faı̈ez Zannad, Brian Claggett, Finnian R. Mc Causland, João Pedro Ferreira, Akshay S. Desai, Ebrahim Barkoudah, John J.V. McMurray, Marc A. Pfeffer, Scott D. Solomon
Topics & Concepts
MedicineSacubitrilValsartanSacubitril, ValsartanInternal medicineEjection fractionHeart failureRenal functionCardiologyHeart failure with preserved ejection fractionBlood pressureHormonal Regulation and HypertensionHeart Failure Treatment and ManagementCardiovascular Function and Risk Factors